Multihance and Fluoxetine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multihance (gadobenate dimeglumine) and Fluoxetine (fluoxetine hydrochloride). Common drug interactions include fibrosis among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Multihance and Fluoxetine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

What is Fluoxetine?

Fluoxetine has active ingredients of fluoxetine hydrochloride. It is often used in depression. eHealthMe is studying from 98,824 Fluoxetine users. Check the latest studies of Fluoxetine.

On Aug, 02, 2026

21 people who take Multihance and Fluoxetine together, and have interactions are studied.

Multihance and Fluoxetine drug interactions.

What are the common drug interactions of Multihance and Fluoxetine, by gender? *:

female:

Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
General physical health deterioration (weak health status)
Scar
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Joint range of motion decreased (disease of joint movement)
Oedema peripheral (superficial swelling)
Pruritus (severe itching of the skin)
Skin induration (an abnormally hard spot or area on the skin)

male:

Emotional distress
Joint range of motion decreased (disease of joint movement)
Skin fibrosis (fibrous tissue formation on skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin tightness
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the common drug interactions of Multihance and Fluoxetine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)

30-39:

Anaphylactic reaction (serious allergic reaction)

40-49:

Hypersensitivity

50-59:

Burning sensation
Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
Deformity (disfigurement)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Joint swelling
Mobility decreased (ability to move is reduced)

60+:

Syncope (loss of consciousness with an inability to maintain postural tone)
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Gait disturbance
Induration (thickening of tissue)
Injury
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Myosclerosis (hardening of muscle tissue)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 4 people, 19.05%
Computerised Tomogram Abdomen: 4 people, 19.05%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 9.52%
Adverse Event: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Multihance and Fluoxetine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously